Sustainability yes, but only few investors for deeptecheCAPITAL NEWS
Is a product recyclable, is production sustainable, what about CO2 emissions? The number of investors focusing on “green” companies has also grown recently. Investments are being made in software and in companies whose capital requirements are low, which are already generating initial sales and promise a quick return.
The challenge is greater for real deep-tech and impact companies that are at the very beginning, require large sums for hardware development and yet have no guarantee of success. In Germany – the country where more young people study natural sciences or engineering than in almost any other country – there is an immense backlog demand in the field of deeptech and impact investments. With the German Future Fund amounting to ten billion euros, politics is going in the right direction. Now it is a matter of turning the outstanding ideas into outstanding products.
eCAPITAL has been facing these challenges for a long time and proves that staying power leads to success. Like, for example, the successful exit of the company sonnen in 2019. In an interview with Jakob Schlandt and Thomas Wendel from TAGESSPIEGEL BACKGROUND, eCAPITAL CEO Paul-Josef Patt reported on successful and promising impact investments of eCAPITAL AG, addressed the German Future Fund and expressed his expectations for German investors.
You can read the entire interview in german here.
Founded in 1999, eCAPITAL is an entrepreneur-led venture capital investor focusing on early- and growth-stage deep-tech companies with a positive impact on society. eCAPITAL is based in Germany and invests with its own funds with a total volume of over € 280 million in the areas of Sustainability, Enterprise Software, Cybersecurity, IoT and New Materials. In addition to financial resources, eCAPITAL offers its portfolio companies strategic support and access to an international network of entrepreneurs, scientists, investors and founders and was lead investor in various deep-tech companies such as sonnen, Novaled or Jedox, which were sold very successfully to international strategists or investors.